Publications
5803 Results
- Journal / Conference
- Clinical Trials 2025 Oct;22(5):571-577. doi: 10.1177/17407745251321371. Epub 2025 Mar 18.
- Year
- 2025
- Research Committee(s)
- Melanoma
- PMID
- PMID40099861
- PMC
- PMC12353050
- Study Number(s)
- S1801
Design considerations for randomized comparisons of neoadjuvant-adjuvant versus adjuvant-only cancer immunotherapy when tumor measurement schedules do not align (SWOG S1801)
- Journal / Conference
- Journal of the National Cancer Institute Monographs Mar 1;2025(68):56-64
- Year
- 2025
- Research Committee(s)
- Cancer Care Delivery
- PMID
- PMID39989035
- PMC
- PMC11848037
- Study Number(s)
- S1415CD
Practical design considerations for cluster randomized controlled trials: lessons learned in community oncology research
- Journal / Conference
- NPJ Digital Medicine
- Year
- 2025
- Research Committee(s)
- Genitourinary
- PMID
- PMID40121304
- PMC
- PMC11929913
- Study Number(s)
- S1314
Predicting Clinical Outcomes in the S1314-COXEN Trial Using a Multimodal Deep Learning Model Integrating Histopathology, Cell Types, and Gene Expression
- Journal / Conference
- Pediatric Blood & Cancer
- Year
- 2025
- PMID
- PMID39865348
Likes and Hashtags: The Impact of Social Media Use on the Emotional Wellbeing of Oncology Professionals
- Journal / Conference
- JCO Precision Oncology
- Year
- 2025
- Research Committee(s)
- Genitourinary
- PMID
- PMID40591902
- Study Number(s)
- CTSU/C90601
Relationship among DNA damage response gene alterations, molecular subtypes, and survival outcomes in patients with metastatic bladder cancer treated on CALGB 90601
- Journal / Conference
- JNCI-Journal of the National Cancer Institute Jan 1;117(1):169-179
- Year
- 2025
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID39212617
- PMC
- PMC11717424
- Study Number(s)
- CTSU/C80405
Plant-Based Diet and Survival Among Patients with Metastatic Colorectal Cancer: Findings from CALGB/SWOG 80405 (Alliance)
- Journal / Conference
- New England Journal of Medicine
- Year
- 2025
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID39282913
- PMC
- PMC11821447
- Study Number(s)
- CTSU/A021602
Phase 3 Trial of Cabozantinib in Previously Treated Advanced Neuroendocrine Tumors
- Journal / Conference
- Journal of the Society for Clinical Data Management Winter;5(1):1-16
- Year
- 2025
- Research Committee(s)
- Cancer Care Delivery and Multiple sites
- PMID
- PMID40510739
- PMC
- PMC12162058
Automating Data Entry from Electronic Health Record to Electronic Data Capture Using Trusted Cloud-based Application in Multi-site Cancer Clinical Trials
- Journal / Conference
- Haematologica. 2025 Dec 1;110(12):3145-3149. doi: 10.3324/haematol.2025.288057. Epub 2025 Jul 3.
- Year
- 2025
- Research Committee(s)
- Lymphoma
- PMID
- PMID40605713
- PMC
- PMC12666269
- Study Number(s)
- S0016
Minimal residual disease status predicts outcomes in patients with follicular lymphoma treated with chemo-immunotherapy on SWOG S0016
- Journal / Conference
- CA-A CANCER JOURNAL FOR CLINICIANS 2025 Jul-Aug;75(4):341-361
- Year
- 2025
- Research Committee(s)
- Cancer Care Delivery
- PMID
- PMID40146038
- PMC
- PMC12223359